|
|
|
|
Fentanyl CitratePharmaLive.com (press release), ...markets four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... FDA Issues Approvable Letter for VIVITROL(TM) (Formerly VIVITREX(R ... Dec 28, 2005 Finanzen.net, ...products in theUnited States: PROVIGIL(R) (modafinil) (C-IV), GABITRIL(R) (tiagabinehydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) (C-II)and ... Cephalon, Inc. Completes Acquisition of Zeneus Holdings Limited Dec 22, 2005 Yahoo! News (press release) ...products in the United States: PROVIGIL® (modafinil) [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... Cephalon, Inc. Completes Acquisition of Zeneus Holdings Limited Dec 22, 2005 Boursorama, ...products in the United States: PROVIGIL(R) (modafinil) [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and ... MGI PHARMA Provides Update on Aquavan(R) Injection Program; Top ... Dec 21, 2005 Business Wire (press release), ...of four different initial bolus doses of Aquavan Injection (2.0, 5.0, 6.5, or 8.0 mg/kg) or midazolam (0.02 mg/kg) following pretreatment with fentanyl citrate ... Cephalon, Inc. Announces Agreement with Ranbaxy Laboratories ... Dec 22, 2005 Yahoo! News (press release) ...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |